AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 69 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $394,312 | -85.8% | 214,300 | -85.4% | 0.00% | -89.7% |
| Q4 2022 | $2,782,170 | +100.7% | 1,464,300 | +601.6% | 0.03% | +81.2% |
| Q2 2021 | $1,386,000 | +15.9% | 208,706 | 0.0% | 0.02% | +6.7% |
| Q1 2021 | $1,196,000 | -19.3% | 208,706 | +25.9% | 0.02% | -28.6% |
| Q4 2020 | $1,482,000 | -23.8% | 165,809 | -0.8% | 0.02% | -30.0% |
| Q3 2020 | $1,945,000 | -54.9% | 167,136 | -37.9% | 0.03% | -53.8% |
| Q2 2020 | $4,313,000 | +134.7% | 269,036 | -12.3% | 0.06% | +75.7% |
| Q1 2020 | $1,838,000 | -32.8% | 306,857 | +48.0% | 0.04% | +2.8% |
| Q4 2019 | $2,737,000 | +26.7% | 207,311 | +19.2% | 0.04% | +16.1% |
| Q3 2019 | $2,161,000 | +35.7% | 173,967 | +75.8% | 0.03% | +47.6% |
| Q2 2019 | $1,593,000 | +11.7% | 98,967 | +112.8% | 0.02% | +31.2% |
| Q3 2018 | $1,426,000 | -57.4% | 46,500 | -62.8% | 0.02% | -46.7% |
| Q2 2018 | $3,349,000 | – | 125,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,530,657 | $23,126,000 | 1.85% |
| TFG Asset Management GP Ltd | 2,500,000 | $16,375,000 | 1.00% |
| Nantahala Capital Management | 2,936,791 | $19,236,000 | 0.61% |
| MYDA Advisors LLC | 171,953 | $1,126,000 | 0.32% |
| SABBY MANAGEMENT, LLC | 300,000 | $1,965,000 | 0.27% |
| Regency Capital Management Inc.\DE | 57,000 | $373,000 | 0.26% |
| Ikarian Capital, LLC | 544,819 | $3,568,000 | 0.25% |
| Eversept Partners, LP | 398,074 | $2,607,385 | 0.18% |
| Henry James International Management Inc. | 54,047 | $354,000 | 0.11% |
| Alphabet Inc. | 698,262 | $4,574,000 | 0.11% |